Prevalence of Hepatitis B Virus Markers among the Women with Breast Cancer.
Venus Fakheri SueiniMehdi Parsa NahadAbdolhosein TalaeizadehMaryam MoradiAmirmohammad AlborziRoya PirmoradiElena LakManoochehr MakvandiPublished in: Asian Pacific journal of cancer prevention : APJCP (2024)
The statistical analysis did not reveal any significant findings (p= 0.315) in the distribution of cancer types across different age groups. Among patients diagnosed with breast cancer, a notable prevalence of 5.5% was observed in HBV markers. The dominant HBV genotype among breast cancer patients was identified as genotype D.